Who owns M.D. Sass Concentrated Value ETF?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of SASS from SEC Form 13F filings across 4 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 4 institutions disclosed 2.9M shares of M.D. Sass Concentrated Value ETF worth $68.2M — about 95% of shares outstanding; the largest disclosed holder is M.D. Sass, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
4
13F holders
$68.2M
value, 2026 filers
95%
of shares outstanding (2.9M sh)
3
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of SASS's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | M.D. Sass, LLC | 2.9M | $66.8M | 2.0% | 93% | +0.1% |
| 2 | JPMORGAN CHASE & CONEW | 26,005 | $611,872 | 0.0% | 0.8% | new |
| 3 | 5T Wealth, LLCNEW | 24,823 | $580,365 | 0.2% | 0.8% | new |
| 4 | GTS SECURITIES LLCNEW | 9,056 | $211,729 | 0.0% | 0.3% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation. Research, not investment advice.